121 related articles for article (PubMed ID: 36963214)
1. Generation of a human induced pluripotent stem cell line (INEUi001-A) from an amyotrophic lateral sclerosis/frontotemporal dementia patient with a C9ORF72 G4C2 genotype of <2 (GGGGCCG) and 10 repeats.
Nievas M; Romorini L; Isaja L; Clas GS; Rodríguez-Varela S; Mucci S; Itzcovich T; de Ambrosi B; Scassa ME; Sevlever GE; Surace EI; Marazita MC
Stem Cell Res; 2023 Jun; 69():103076. PubMed ID: 36963214
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene.
Lin HY; Tsai LK; Cheng YC; Lu HE; Huang CY; Hsieh PCH; Lin CH
Stem Cell Res; 2020 Apr; 44():101734. PubMed ID: 32151952
[TBL] [Abstract][Full Text] [Related]
3. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
[TBL] [Abstract][Full Text] [Related]
4. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
[TBL] [Abstract][Full Text] [Related]
5. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Shpilyukova YA; Fedotova EY; Abramycheva NY; Kochergin IA; Zakroyshchikova IV; Zakharova MN; Illarioshkin SN
Bull Exp Biol Med; 2020 Sep; 169(5):673-676. PubMed ID: 32990847
[TBL] [Abstract][Full Text] [Related]
6. Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
Ababneh NA; Scaber J; Flynn R; Douglas A; Barbagallo P; Candalija A; Turner MR; Sims D; Dafinca R; Cowley SA; Talbot K
Hum Mol Genet; 2020 Aug; 29(13):2200-2217. PubMed ID: 32504093
[TBL] [Abstract][Full Text] [Related]
7. Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients.
Jiang L; Tracey TJ; Gill MK; Howe SL; Power DT; Bharti V; McCombe PA; Henderson RD; Steyn FJ; Ngo ST
Stem Cell Res; 2024 Aug; 78():103447. PubMed ID: 38796984
[TBL] [Abstract][Full Text] [Related]
8. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
[TBL] [Abstract][Full Text] [Related]
9. All in the Family: Repeats and ALS/FTD.
Pattamatta A; Cleary JD; Ranum LPW
Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
[TBL] [Abstract][Full Text] [Related]
10. Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member.
Lattuada C; Santangelo S; Peverelli S; McGoldrick P; Rogaeva E; Zinman L; Haase G; Géli V; Silani V; Robertson J; Ratti A; Bossolasco P
Stem Cell Res; 2023 Feb; 66():102998. PubMed ID: 36528014
[TBL] [Abstract][Full Text] [Related]
11. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
12. Poly(GP) proteins are a useful pharmacodynamic marker for
Gendron TF; Chew J; Stankowski JN; Hayes LR; Zhang YJ; Prudencio M; Carlomagno Y; Daughrity LM; Jansen-West K; Perkerson EA; O'Raw A; Cook C; Pregent L; Belzil V; van Blitterswijk M; Tabassian LJ; Lee CW; Yue M; Tong J; Song Y; Castanedes-Casey M; Rousseau L; Phillips V; Dickson DW; Rademakers R; Fryer JD; Rush BK; Pedraza O; Caputo AM; Desaro P; Palmucci C; Robertson A; Heckman MG; Diehl NN; Wiggs E; Tierney M; Braun L; Farren J; Lacomis D; Ladha S; Fournier CN; McCluskey LF; Elman LB; Toledo JB; McBride JD; Tiloca C; Morelli C; Poletti B; Solca F; Prelle A; Wuu J; Jockel-Balsarotti J; Rigo F; Ambrose C; Datta A; Yang W; Raitcheva D; Antognetti G; McCampbell A; Van Swieten JC; Miller BL; Boxer AL; Brown RH; Bowser R; Miller TM; Trojanowski JQ; Grossman M; Berry JD; Hu WT; Ratti A; Traynor BJ; Disney MD; Benatar M; Silani V; Glass JD; Floeter MK; Rothstein JD; Boylan KB; Petrucelli L
Sci Transl Med; 2017 Mar; 9(383):. PubMed ID: 28356511
[TBL] [Abstract][Full Text] [Related]
13. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
14. Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China.
Jiao B; Tang B; Liu X; Yan X; Zhou L; Yang Y; Wang J; Xia K; Shen L
Neurobiol Aging; 2014 Apr; 35(4):936.e19-22. PubMed ID: 24269022
[TBL] [Abstract][Full Text] [Related]
15. G
Coyne AN; Zaepfel BL; Hayes L; Fitchman B; Salzberg Y; Luo EC; Bowen K; Trost H; Aigner S; Rigo F; Yeo GW; Harel A; Svendsen CN; Sareen D; Rothstein JD
Neuron; 2020 Sep; 107(6):1124-1140.e11. PubMed ID: 32673563
[TBL] [Abstract][Full Text] [Related]
16. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia.
Aoki Y; Manzano R; Lee Y; Dafinca R; Aoki M; Douglas AGL; Varela MA; Sathyaprakash C; Scaber J; Barbagallo P; Vader P; Mäger I; Ezzat K; Turner MR; Ito N; Gasco S; Ohbayashi N; El Andaloussi S; Takeda S; Fukuda M; Talbot K; Wood MJA
Brain; 2017 Apr; 140(4):887-897. PubMed ID: 28334866
[TBL] [Abstract][Full Text] [Related]
17. The progress in
Jiang L; Zhang T; Lu K; Qi S
Small GTPases; 2022 Jan; 13(1):56-76. PubMed ID: 33663328
[TBL] [Abstract][Full Text] [Related]
18. The frequency of the C9orf72 expansion in a Brazilian population.
Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
[TBL] [Abstract][Full Text] [Related]
19. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.
Ortega JA; Daley EL; Kour S; Samani M; Tellez L; Smith HS; Hall EA; Esengul YT; Tsai YH; Gendron TF; Donnelly CJ; Siddique T; Savas JN; Pandey UB; Kiskinis E
Neuron; 2020 Apr; 106(1):90-107.e13. PubMed ID: 32059759
[TBL] [Abstract][Full Text] [Related]
20. Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G
Czuppa M; Dhingra A; Zhou Q; Schludi C; König L; Scharf E; Farny D; Dalmia A; Täger J; Castillo-Lizardo M; Katona E; Mori K; Aumer T; Schelter F; Müller M; Carell T; Kalliokoski T; Messinger J; Rizzu P; Heutink P; Edbauer D
Cell Rep; 2022 Jun; 39(10):110913. PubMed ID: 35675776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
